What is the appropriate concentration and maximum dose of bupivacaine for subcutaneous infiltration in an adult patient without amide‑type anesthetic allergy?

Bupivacaine for Subcutaneous Local Anesthesia

For subcutaneous infiltration in adults, use 0.25% bupivacaine with a maximum dose of 175 mg without epinephrine or 225 mg with epinephrine 1:200,000, administered incrementally with aspiration before each injection. 1

Concentration Selection

The FDA-approved concentration for local infiltration is 0.25% bupivacaine 1. This concentration produces complete sensory block while providing incomplete motor block, which is appropriate for procedures where muscle relaxation is not required 1. Higher concentrations (0.5% and 0.75%) are reserved for nerve blocks, epidural anesthesia, and procedures requiring complete motor blockade 1.

Maximum Dosing

The FDA label establishes clear maximum doses for bupivacaine 1:

• Without epinephrine: 175 mg maximum single dose
• With epinephrine 1:200,000: 225 mg maximum single dose
• Daily maximum: 400 mg total (when repeated doses are needed)
• Minimum interval between doses: 3 hours

For a 70 kg adult, this translates to approximately 2.5 mg/kg without epinephrine or 3.2 mg/kg with epinephrine. Research supports a maximum of 150 mg for subcutaneous infiltration 2, which aligns conservatively with FDA guidance.

Critical Safety Measures

To minimize the risk of local anesthetic systemic toxicity (LAST), the FDA mandates 1:

1. Use the lowest effective dose - start conservatively and titrate as needed
2. Aspirate before each injection - prevents direct intravascular administration
3. Use incremental injections - inject 3-5 mL aliquots with pauses between
4. Continuous patient monitoring - watch for early signs of toxicity (perioral numbness, tinnitus, confusion, seizures)

Plasma concentrations remain well below toxic thresholds (2000 ng/mL for neurotoxicity, 4000 ng/mL for cardiotoxicity) when proper technique is used 3, 4.

Practical Application

For a typical adult patient:

• 0.25% bupivacaine = 2.5 mg/mL
• Maximum volume without epinephrine: 70 mL (175 mg)
• Maximum volume with epinephrine: 90 mL (225 mg)

The addition of epinephrine prolongs anesthetic duration and allows for higher total doses by slowing systemic absorption 1.

Special Populations

Reduce doses for 1:

• Elderly patients
• Debilitated patients
• Cardiac disease
• Liver disease

The FDA does not provide specific pediatric dosing for bupivacaine in patients under 12 years 1.

Common Pitfalls

• Do not use multiple-dose vials for epidural/caudal blocks - they contain preservatives 1
• Avoid rapid bolus injection - increases risk of systemic toxicity
• Do not exceed 400 mg in 24 hours - even with repeated procedures 1
• Never use 0.75% concentration for obstetrical anesthesia 1

The onset of 0.25% bupivacaine may be slower than higher concentrations, but duration of action is prolonged (typically 4-8 hours with epinephrine) 1.